Could SGLT2 inhibitors improve outcomes in patients with heart failure and significant valvular heart disease? Need for action
Crossref DOI link: https://doi.org/10.1007/s10741-024-10467-x
Published Online: 2024-11-20
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kamperidis, Vasileios
Anastasiou, Vasileios
Ziakas, Antonios
Text and Data Mining valid from 2024-11-20
Version of Record valid from 2024-11-20
Article History
Accepted: 11 November 2024
First Online: 20 November 2024
Declarations
:
: The authors declare no competing interests.